Connect Biopharma Holdings (CNTB) Operating Leases (2020 - 2026)

Connect Biopharma Holdings has disclosed Operating Leases across 7 years of filings, most recently posting $596000.0 for Q2 2026.

• In Q2 2026, Operating Leases fell 31.49% year-over-year to $596000.0; the TTM figure through Jun 2026 stood at $596000.0 (down 31.49% YoY), while the FY2025 annual figure was $368000.0, up 1433.33% from the prior year.
• Operating Leases came in at $596000.0 for Q2 2026 at Connect Biopharma Holdings, down from $693000.0 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $940000.0 in Q1 2025 to a low of $24000.0 in Q4 2024.
• Average Operating Leases over 5 years is $472882.4, with a median of $351500.0 recorded in 2022.
• Year-over-year, Operating Leases tumbled 86.67% in 2024 and soared 1433.33% in 2025.
• Over 5 years, Operating Leases stood at $239589.3 in 2022, then declined by 24.87% to $180000.0 in 2023, then plunged by 86.67% to $24000.0 in 2024, then soared by 1433.33% to $368000.0 in 2025, then surged by 61.96% to $596000.0 in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $596000.0 in Q2 2026, $693000.0 in Q1 2026, and $368000.0 in Q4 2025.